PREVENTION AND EARLY DETECTION OF CANCER

As much as 70% of cancer worldwide may be preventable. In fact, despite enormous progress in treatment, it is likely that the greatest reduction in cancer deaths to date is the result of cancer prevention and early detection. New technologies, combined with advances in understanding the genetics and cell biology of cancer, could help to further reduce the burden of cancer through simpler, cheaper, more precise, and more efficient approaches.  This one-day symposium will include discussion of how to accelerate our efforts to find and intercept disease at the earliest possible stage, and, ideally, prevent many cancers altogether.

Where?

Kresge Auditorium, MIT

When?

June 10, 2016

9:00 am – 4:10 pm

Register Here (Members of the media interested in attending should email Andrew Carleen at acarleen@mit.edu)

List of Speakers

Angela Belcher

Koch Institute, MIT

“Interfacing biology and engineering to find tiny ovarian tumors”

Sangeeta Bhatia

Koch Institute, MIT

“Activity-based biomarkers for noninvasive cancer detection” 

David Hunter

Harvard T.H. Chan School of Public Health

“The realistically preventable fraction of cancers worldwide”

Elizabeth Jaffee

Sidney Kimmel Cancer Center at Johns Hopkins University

“Vaccine-induced immunity against non-viral cancer genes to prevent pancreatic cancer”

Barry Kramer

Division of Cancer Prevention, NCI

“Principles of cancer screening: The clash between science and intuition”

Doug Lowy

National Cancer Institute

“The HPV vaccine: FDA approval was only the beginning”

Bert Vogelstein

Johns Hopkins University

“Cancer genomes and their implications for prevention”

Heidi Williams

Department of Economics, MIT

“Do firms underinvest in long-term research? Evidence from cancer ciinical trials”

Omer Yilmaz

Koch Institute, MIT

“Dietary control of stem cells in obesity and cancer”

 

Remarks by

Nancy Hopkins

Koch Institute, MIT

Edward Scolnick

Stanley Center for Psychiatric Research, Broad Institute

 

Panel Discussion – “Challenges for implementing early detection and prevention research”

Sangeeta Bhatia, William Hait (Janssen Research & Development), Doug Lowy, Edward Scolnick, Bert Vogelstein, and Heidi Williams

Tyler Jacks (Moderator)

 

We gratefully acknowledge our:

AFFILIATES

Janssen Research & Development, LLC

Omega Funds

Thermo Fisher Scientific

COLLABORATORS

Agilent Technologies

GE Healthcare Life Sciences

GRAIL

Third Rock Ventures, LLC

SPONSORS

Alnylam Pharmaceuticals

Calico

Cell Signaling Technology, Inc.

Genentech

Molquant, Inc.

New England Biolabs

Wilson Sonsini Goodrich & Rosati

VENDORS

ACEA Biosciences

Beckman Coulter

BioLegend

Bioscience

BioTek Instruments

Cell Signaling Technology

Kapa Biosystems

Macrogen Clinical Laboratory

Nexcelom

PeproTech, Inc.

Qiagen

Transnetyx, Inc.